Session View

Monday 27 February, Morning

Registration

08:00 - 09:15

Welcome

Adam Cunningham, BactiVac Network Co-Director, University of Birmimgham, UK

09:15 - 09:25

Keynote Lecture - Affinity maturation and persistence of antibody responses

Professor Ian MacLennan, Emeritus Professor of Immunology, University of Birmingham, UK

09:25 - 10:00

Session 1: AMR - the problem in the context of human and veterinary health

How the global burden estimates of AMR are helping to implement local action and combat AMR

Catrin Moore, Senior Lecturer, St George's University of London, UK

10:00 - 10:30
The role of vaccines in reducing AMR: WHO strategy and priorities

Mateusz Hasso-Agopsowicz, Technical Officer, WHO, Switzerland

10:30 - 11:00
Refreshments, networking and Poster viewing

11:00 - 11:30
Vaccines for animal and zoonotic bacterial pathogens

Mark Stevens, Chair of Microbial Pathogenesis & Deputy Director, The Roslin Institute, University of Edinburgh, UK

11:30 - 12:00
Selected Abstract Presentations: The development of bovine herpesvirus 4 (BoHV-4) as a safe, inexpensive, single dose vaccine to control Streptococcus suis infection in domestic pigs

Hester Nichols, Project Lead, The Vaccine Group Ltd, UK

12:00 - 12:13
Selected Abstract Presentations: Vaccination and Niche Competition for Targeted Exclusion of Antibiotic Resistant Bacteria from the Gut

Verena Lentsch, PhD student, ETH Zurich, Switzerland

12:13 - 12:26
Selected Abstract Presentations: Multispecies Quartet Nanocages Elicit a Broad Antibody Response for Proactive Vaccinology

Rory Hills, Graduate student, University of Oxford, UK

12:26 - 12:39
Lunch, networking and poster viewing

12:40 - 13:40

Monday 27 February, Afternoon

Session 2: The strengths and gaps in using vaccination to limit AMR

The strengths and gaps in using vaccination to limit AMR

Angela Brueggemann, Professor of Infectious Disease Epidemiology, University of Oxford, UK

13:40 - 14:10
Selected Abstract Presentations: Safety and immunogenicity of a Klebsiella pneumoniae tetravalent bioconjugate vaccine (Kleb4V) administered to healthy adults: A FTIH phase I/II randomized and controlled study

Cristina Alaimo, Clinical Director, LimmaTech Biologics, Switzerland

14:10 - 14:23
Selected Abstract Presentations: Development of an outer membrane vesicle based vaccine for Acinetobacter baumannii

Sophie Higham, Research Assistant, Imperial College London, UK

14:23 - 14:36
Selected Abstract Presentations: 3. Protein array screening as a tool to identify new carrier proteins for the development of an innovative conjugated vaccine against Streptococcus pneumoniae

Giuseppe Ercoli, Research Associate, UCL, UK

14:36 - 14:39

Session 3: Host responses to different bacterial antigens and vaccines - key lessons learned

Understanding the interplay between antibiotic resistant infections and the innate immune system to design vaccines

Jose Bengoechea, Director, Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK

14:50 - 15:20
How antibodies and complement orchestrate protective immune responses against bacteria

Suzan HM Rooijakkers, Professor, University Medical Centre Utrecht, The Netherlands

15:20 - 15:50
Speed networking briefing

15:50 - 16:00
Refreshments, networking and Poster viewing

16:00 - 16:15
Speed networking session

16:15 - 17:30

Drinks reception

17:30 - 19:00

Conference Dinner

19:00 - 21:00

Tuesday 28 February, Morning

Session 3 continued: Host responses to different bacterial antigens and vaccines - key lessons learned

Next-generation pertussis vaccines

Camille Locht, Research Director, Inserm / Institut Pasteur de Lille, France

09:00 - 09:30
Selected Abstract Presentations: High Throughput Phenotypic Characterisation of Klebsiella: Implications for Vaccine Design

Caroline Zellmer, PhD student, University of Cambridge, UK

09:30 - 09:43
Selected Abstract Presentations: GMMA and monoclonal antibodies platforms to fight shigellosis

Omar Rossi, Lab Head serology and immunology, GSK Vaccines Institute for Global Health, Italy

09:43 - 09:56
Selected Abstract Presentations: From the Typhoid Conjugate Vaccine approved against Salmonella Typhi toward a bivalent vaccine candidate targeting both Salmonella Typhi and Paratyphi A

Francesca Micoli, Senior Project Leader and Director of GVGH Innovation Academy, GSK Vaccines Institute for Global Health, Italy

09:56 - 10:09

Session 4: Enhancing the use of existing and novel platforms, technologies, adjuvants - the spectre of 'Pathogen X'

Novel vaccine candidates protect against Salmonella challenge

Ian Henderson, Executive Director, Institute for Molecular Bioscience, The University of Queensland, Australia

10:10 - 10:40
Refreshements, networking and Poster viewing

10:40 - 11:10
Technology platform for the production of custom-made recombinant glycoconjugate vaccines

Brendan Wren, London School of Hygiene and Tropical Medicine, UK

11:10 - 11:40
Defining Correlates of immunity to Shigella

Galit Alter, VP Immunology, Moderna, USA

11:40 - 12:10
Lunch, networking and poster viewing

12:10 - 13:10

Tuesday 28 February, Afternoon

Session 5: The targeting of bacterial pathogens to reduce AMR - addressing unmet needs

Salmonella combination vaccines - moving beyond typhoid

Cal MacLennan, BactiVac Network Director, University of Birmingham, UK

13:10 - 13:40
Using Viral Vectors as Vaccines Against Bacteria: potential to combat AMR

Dr Christine Rollier, Professor of Vaccinology, University of Surrey, UK

13:40 - 14:10
Refreshments, networking and Poster viewing

14:10 - 14:40
Controlled human infection with Neisseria lactamica to understand meningococcal colonisation

Adam Dale, NIHR Academic Clinical Lecturer in Infectious Diseases & Medical Microbiology, University of Southampton, UK

14:40 - 15:10
Human challenge models of paratyphoid infection and vaccination

Naina McCann, Clinical Research Fellow / DPhil Student, Oxford Vaccine Group, UK

15:10 - 15:40
Long-lasting immune responses induced by Salmonella porins vaccine

Constantino López-Macías, Medical Research Unit on Immunochemistry, National Medical Centre “Siglo XXI”/Mexican Institute for Social Security, Mexico

15:40 - 16:10
Closing remarks and poster prizes

Adam Cunningham, BactiVac Network Co-Director, University of Birmingham, UK

16:10 - 16:30

Lecture View

Registration

Welcome

Keynote Lecture - Affinity maturation and persistence of antibody responses

How the global burden estimates of AMR are helping to implement local action and combat AMR

The role of vaccines in reducing AMR: WHO strategy and priorities

Refreshments, networking and Poster viewing

Vaccines for animal and zoonotic bacterial pathogens

Selected Abstract Presentations: The development of bovine herpesvirus 4 (BoHV-4) as a safe, inexpensive, single dose vaccine to control Streptococcus suis infection in domestic pigs

Selected Abstract Presentations: Vaccination and Niche Competition for Targeted Exclusion of Antibiotic Resistant Bacteria from the Gut

Selected Abstract Presentations: Multispecies Quartet Nanocages Elicit a Broad Antibody Response for Proactive Vaccinology

Lunch, networking and poster viewing

The strengths and gaps in using vaccination to limit AMR

Selected Abstract Presentations: Safety and immunogenicity of a Klebsiella pneumoniae tetravalent bioconjugate vaccine (Kleb4V) administered to healthy adults: A FTIH phase I/II randomized and controlled study

Selected Abstract Presentations: Development of an outer membrane vesicle based vaccine for Acinetobacter baumannii

Selected Abstract Presentations: 3. Protein array screening as a tool to identify new carrier proteins for the development of an innovative conjugated vaccine against Streptococcus pneumoniae

Understanding the interplay between antibiotic resistant infections and the innate immune system to design vaccines

How antibodies and complement orchestrate protective immune responses against bacteria

Speed networking briefing

Refreshments, networking and Poster viewing

Speed networking session

Drinks reception

Conference Dinner

Next-generation pertussis vaccines

Selected Abstract Presentations: High Throughput Phenotypic Characterisation of Klebsiella: Implications for Vaccine Design

Selected Abstract Presentations: GMMA and monoclonal antibodies platforms to fight shigellosis

Selected Abstract Presentations: From the Typhoid Conjugate Vaccine approved against Salmonella Typhi toward a bivalent vaccine candidate targeting both Salmonella Typhi and Paratyphi A

Novel vaccine candidates protect against Salmonella challenge

Refreshements, networking and Poster viewing

Technology platform for the production of custom-made recombinant glycoconjugate vaccines

Defining Correlates of immunity to Shigella

Lunch, networking and poster viewing

Salmonella combination vaccines - moving beyond typhoid

Using Viral Vectors as Vaccines Against Bacteria: potential to combat AMR

Refreshments, networking and Poster viewing

Controlled human infection with Neisseria lactamica to understand meningococcal colonisation

Human challenge models of paratyphoid infection and vaccination

Long-lasting immune responses induced by Salmonella porins vaccine

Closing remarks and poster prizes

Registration

Welcome

Keynote Lecture - Affinity maturation and persistence of antibody responses

How the global burden estimates of AMR are helping to implement local action and combat AMR

The role of vaccines in reducing AMR: WHO strategy and priorities

Refreshments, networking and Poster viewing

Vaccines for animal and zoonotic bacterial pathogens

Selected Abstract Presentations: The development of bovine herpesvirus 4 (BoHV-4) as a safe, inexpensive, single dose vaccine to control Streptococcus suis infection in domestic pigs

Selected Abstract Presentations: Vaccination and Niche Competition for Targeted Exclusion of Antibiotic Resistant Bacteria from the Gut

Selected Abstract Presentations: Multispecies Quartet Nanocages Elicit a Broad Antibody Response for Proactive Vaccinology

Lunch, networking and poster viewing

Lunch, networking and poster viewing

The strengths and gaps in using vaccination to limit AMR

Selected Abstract Presentations: Safety and immunogenicity of a Klebsiella pneumoniae tetravalent bioconjugate vaccine (Kleb4V) administered to healthy adults: A FTIH phase I/II randomized and controlled study

Selected Abstract Presentations: Development of an outer membrane vesicle based vaccine for Acinetobacter baumannii

Selected Abstract Presentations: 3. Protein array screening as a tool to identify new carrier proteins for the development of an innovative conjugated vaccine against Streptococcus pneumoniae

Understanding the interplay between antibiotic resistant infections and the innate immune system to design vaccines

How antibodies and complement orchestrate protective immune responses against bacteria

Speed networking briefing

Refreshments, networking and Poster viewing

Speed networking session

Drinks reception

Conference Dinner

Next-generation pertussis vaccines

Selected Abstract Presentations: High Throughput Phenotypic Characterisation of Klebsiella: Implications for Vaccine Design

Selected Abstract Presentations: GMMA and monoclonal antibodies platforms to fight shigellosis

Selected Abstract Presentations: From the Typhoid Conjugate Vaccine approved against Salmonella Typhi toward a bivalent vaccine candidate targeting both Salmonella Typhi and Paratyphi A

Novel vaccine candidates protect against Salmonella challenge

Refreshements, networking and Poster viewing

Technology platform for the production of custom-made recombinant glycoconjugate vaccines

Defining Correlates of immunity to Shigella

Lunch, networking and poster viewing

Lunch, networking and poster viewing

Salmonella combination vaccines - moving beyond typhoid

Using Viral Vectors as Vaccines Against Bacteria: potential to combat AMR

Refreshments, networking and Poster viewing

Controlled human infection with Neisseria lactamica to understand meningococcal colonisation

Human challenge models of paratyphoid infection and vaccination

Long-lasting immune responses induced by Salmonella porins vaccine

Closing remarks and poster prizes